John M. Evans Beam Therapeutics Inc. (BEAM) insider trading activity

John M. Evans is CEO of Beam Therapeutics Inc.. Currently has a direct ownership of 938,659 shares of BEAM, which is worth approximately $23.5 Million. The most recent transaction as insider was on Apr 23, 2021, when has been sold 6,000 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $6,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 939K

5.98% 3M change

16.04% 12M change

Total Value Held $23.5 Million

John M. Evans Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 23 2021	BUY Exercise of conversion of derivative security	$6,180 $1.03 p/Share	6,000 Added 0.58%	1,021,429 Common Stock
Apr 21 2021	SELL Open market or private sale	$1,751,500 $70.06 p/Share	25,000 Reduced 2.4%	1,015,429 Common Stock
Mar 31 2021	BUY Small Acquisition	-	32 Added 0.0%	1,040,429 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	69,375 Added 6.25%	1,040,332 Common Stock
Mar 22 2021	BUY Small Acquisition	-	32 Added 0.0%	1,040,397 Common Stock
Mar 18 2021	BUY Small Acquisition	-	33 Added 0.0%	1,040,365 Common Stock
Dec 30 2020	SELL Open market or private sale	$1,904,197 $85.39 p/Share	22,300 Reduced 2.25%	970,957 Common Stock
Apr 16 2020	BUY Exercise of conversion of derivative security	$118,450 $1.03 p/Share	115,000 Added 10.38%	993,257 Common Stock

Also insider at

VERV

Verve Therapeutics, Inc. Healthcare

Director

JME

John M. Evans

CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Value

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM

Account